Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases. | Case Rep Endocrinol | 2022 | 36160179 | PubTator, text mining | PubMed |
| Role of B cells as antigen presenting cells. | Front Immunol | 2022 | 36159874 | PubTator, text mining | PubMed |
| Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma. | Front Oncol | 2022 | 36158683 | PubTator, text mining | PubMed |
| Occurrence of MYD88L265P and CD79B mutations in diffuse large b cell lymphoma with bone marrow infiltration: A case report. | World J Clin Cases | 2022 | 36158496 | PubTator, text mining | PubMed |
| Next-Generation Sequencing Highlights of Diffuse Large B-cell Lymphoma in a Tertiary Care Hospital in North India. | Cureus | 2022 | 36158348 | PubTator, text mining | PubMed |
| Single-cell landscape analysis reveals distinct regression trajectories and novel prognostic biomarkers in primary neuroblastoma. | Genes Dis | 2022 | 36157484 | PubTator, text mining | PubMed |
| New methodology of TMB assessment from tissue and liquid biopsy in NSCLC. | PLoS One | 2022 | 36155654 | PubTator, text mining | PubMed |
| Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma. | Genome Med | 2022 | 36153593 | PubTator, text mining | PubMed |
| Cytomegalovirus-specific neutralizing antibodies effectively prevent uncontrolled infection after allogeneic hematopoietic stem cell transplantation. | iScience | 2022 | 36147955 | PubTator, text mining | PubMed |
| Atopic Dermatitis-like Genodermatosis: Disease Diagnosis and Management. | Diagnostics (Basel) | 2022 | 36140582 | PubTator, text mining | PubMed |
| Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021. | Biomedicines | 2022 | 36140426 | PubTator, text mining | PubMed |
| The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target. | Biomedicines | 2022 | 36140335 | PubTator, text mining | PubMed |
| IgG+ Extracellular Vesicles Measure Therapeutic Response in Advanced Pancreatic Cancer. | Cells | 2022 | 36139375 | PubTator, text mining | PubMed |
| Bruton tyrosine kinase inhibitors in B-cell lymphoma: beyond the antitumour effect. | Exp Hematol Oncol | 2022 | 36138486 | PubTator, text mining | PubMed |
| Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation. | Nat Genet | 2022 | 36138229 | PubTator, text mining | PubMed |
| Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming. | Mol Cancer | 2022 | 36131282 | PubTator, text mining | PubMed |
| Prognostic significance of BLK expression in R-CHOP treated diffuse large B-cell lymphoma. | J Pathol Transl Med | 2022 | 36128864 | PubTator, text mining | PubMed |
| Combining single-cell RNA sequencing of peripheral blood mononuclear cells and exosomal transcriptome to reveal the cellular and genetic profiles in COPD. | Respir Res | 2022 | 36127695 | PubTator, text mining | PubMed |
| Optimization of Cold Chain Distribution Route with Mixed Time Window considering Customer Priority. | Comput Intell Neurosci | 2022 | 36120673 | PubTator, text mining | PubMed |
| Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large B-Cell Lymphoma. | Mediterr J Hematol Infect Dis | 2022 | 36119461 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=56